Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
03/08/2026 11:31
BRIEF-Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees Aug 3 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd GLAX.NS:
GLAXOSMITHKLINE PHARMA Q1 CONSOL PROFIT 2.37 BILLION RUPEES
GLAXOSMITHKLINE PHARMA Q1 CONSOL REVENUE FROM OPERATIONS 9.38 BILLION RUPEES
GLAXOSMITHKLINE PHARMACEUTICALS - RE-APPOINTS BHUSHAN AKSHIKAR AS MD
Source text: ID:nnAZN4TBGEK
Further company coverage: GLAX.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees